TY - JOUR T1 - Norepinephrine Directly Activates Adult Hippocampal Precursors via β<sub>3</sub>-Adrenergic Receptors JF - The Journal of Neuroscience JO - J. Neurosci. SP - 2795 LP - 2806 DO - 10.1523/JNEUROSCI.3780-09.2010 VL - 30 IS - 7 AU - Dhanisha J. Jhaveri AU - Eirinn W. Mackay AU - Adam S. Hamlin AU - Swananda V. Marathe AU - L. Sanjay Nandam AU - Vidita A. Vaidya AU - Perry F. Bartlett Y1 - 2010/02/17 UR - http://www.jneurosci.org/content/30/7/2795.abstract N2 - Adult hippocampal neurogenesis is a critical form of cellular plasticity that is greatly influenced by neural activity. Among the neurotransmitters that are widely implicated in regulating this process are serotonin and norepinephrine, levels of which are modulated by stress, depression and clinical antidepressants. However, studies to date have failed to address a direct role for either neurotransmitter in regulating hippocampal precursor activity. Here we show that norepinephrine but not serotonin directly activates self-renewing and multipotent neural precursors, including stem cells, from the hippocampus of adult mice. Mechanistically, we provide evidence that β3-adrenergic receptors, which are preferentially expressed on a Hes5-expressing precursor population in the subgranular zone (SGZ), mediate this norepinephrine-dependent activation. Moreover, intrahippocampal injection of a selective β3-adrenergic receptor agonist in vivo increases the number of proliferating cells in the SGZ. Similarly, systemic injection of the β-adrenergic receptor agonist isoproterenol not only results in enhancement of proliferation in the SGZ but also leads to an increase in the percentage of nestin/glial fibrillary acidic protein double-positive neural precursors in vivo. Finally, using a novel ex vivo “slice-sphere” assay that maintains an intact neurogenic niche, we demonstrate that antidepressants that selectively block the reuptake of norepinephrine, but not serotonin, robustly increase hippocampal precursor activity via β-adrenergic receptors. These findings suggest that the activation of neurogenic precursors and stem cells via β3-adrenergic receptors could be a potent mechanism to increase neuronal production, providing a putative target for the development of novel antidepressants. ER -